Altimmune, Inc. (ALT) Financials

ALT Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 166.6 million 16.2 million
2023-06-30 183.3 million 15.6 million
2023-03-31 187.1 million 19.4 million
2022-12-31 206.9 million 21.6 million

ALT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -20.5 million 2.7 million
2023-06-30 -19.4 million 2.8 million
2023-03-31 -19.5 million 2.7 million
2022-12-31 -17.3 million 1.9 million

ALT Net Income

No data available :(

ALT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 140.8 million - 788000
2023-06-30 160.0 million 4.2 million 903000
2023-03-31 165.7 million 4.4 million 1.0 million
2022-12-31 184.9 million - 1.1 million

ALT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 53.6 million
2023-06-30 50.7 million
2023-03-31 50.1 million
2022-12-31 50.0 million

ALT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 18.4 million 4.5 million -
2023-06-30 4000 13.3 million 4.8 million -
2023-03-31 51000 17.2 million 4.5 million -
2022-12-31 38000 19.2 million 3.8 million -

ALT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 362000 18.4 million
2023-06-30 6000 13.3 million
2023-03-31 21000 -356000
2022-12-31 -110000 110000

ALT

Price: $7.19

52 week price:
2.09
14.84

Earnings Per Share: -1.66 USD

P/E Ratio: -6.75

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 680703

Ebitda: -31.4 million

Market Capitalization: 567.9 million

Links: